Direktorat Registrasi ObatValid

PACLITAXEL

Claim this product
BPOM Number
GKL1222251143A1
Approved
21 November 2024
Expiry
29 June 2025
Form
INJEKSI; 6 MG

About This Registration

PACLITAXEL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1222251143A1. Its current registration status is Valid, with the licence valid until 29 June 2025. The product is registered to SANBE FARMA and manufactured by SANBE FARMA - INDONESIA. BPOM first approved this registration in August 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 16,7 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

PACLITAXEL

Market Intelligence

Owner Portfolio
SANBE FARMA holds 554 BPOM registrations
Manufacturer Scale
SANBE FARMA - INDONESIA produces 490 registered products
Registration Age
Registered for 6 years, 1 month
Expiry Status
Expired 452 days ago

FDA Cross-Reference

via openFDA
Generic Name
PACLITAXEL
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1